Prospective, Multicentre, Non-interventional (Observational) Study of VANTAS for the Treatment of Patients With Advanced Prostate Cancer.
Phase of Trial: Phase IV
Latest Information Update: 21 Oct 2014
At a glance
- Drugs Histrelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Orion Pharma
- 10 Jun 2017 Biomarkers information updated
- 15 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jan 2013 Planned End Date (Jun 2014) added as reported by ClinicalTrials.gov.